Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients
NCT02355509Phase 4Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Jan 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in glucose intolerance comparing Acarbose with Placebo (2 arms). Primary endpoint: Change in postprandial oxidized LDL at 3 months. Started Jan 2010; status: completed.
02
Drugs
acarbose
03
Conditions
glucose intolerance
Beyond the preview
Go deeper on NCT02355509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355509.